Results 31 to 40 of about 269,977 (355)

Co-evolution of Vaccination Behavior and Perceived Vaccination Risk can lead to a Stag-Hunt like Game [PDF]

open access: yes, 2022
Voluntary vaccination is effective to prevent infectious diseases from spreading. Both vaccination behavior and cognition of the vaccination risk play important roles in individual vaccination decision making. However, it is not clear how the co-evolution of the two shapes the population-wide vaccination behavior.
arxiv   +1 more source

A CRITIQUE ON CANCER VACCINE. [PDF]

open access: yesInternational Journal of Advanced Research, 2018
The goal of a successful vaccine is to prepare the immune system for invasion of a foreign pathogen and teach them to recognize antigens as well as reduce the risk of transmission. In the field of cancer, vaccines are found to be the latest discovery. Provenge?
Sudha M   +3 more
openaire   +3 more sources

Development of a Human Cytomegalovirus (HCMV)-Based Therapeutic Cancer Vaccine Uncovers a Previously Unsuspected Viral Block of MHC Class I Antigen Presentation [PDF]

open access: yes, 2019
Human cytomegalovirus (HCMV) induces a uniquely high frequency of virus-specific effector/memory CD8+ T-cells, a phenomenon termed “memory inflation”.
Abate   +109 more
core   +1 more source

Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death

open access: yesJournal of Experimental & Clinical Cancer Research, 2022
Emerging evidence has demonstrated that radiotherapy (RT) can not only cause direct damage to cancer cells but also lead to immunogenic cell death (ICD), which involves the activation of host antitumor immune response in tumor immune microenvironment ...
Xuhui Bao, Liyi Xie
doaj   +1 more source

Cancer vaccines

open access: yesBritish Journal of Surgery, 2007
Stormy ...
R, Kiessling, A, Choudhury
openaire   +2 more sources

Regulation of Tumor Immunity by Tumor/Dendritic Cell Fusions [PDF]

open access: yes, 2010
The goal of cancer vaccines is to induce antitumor immunity that ultimately will reduce tumor burden in tumor environment. Several strategies involving dendritic cells- (DCs)- based vaccine incorporating different tumor-associated antigens to induce ...
Gong, Jianlin   +10 more
core   +4 more sources

Complete Rescue of HTLV-1p12KO Infectivity by Depletion of Monocytes Together with NK and CD8+ T Cells

open access: yesPathogens
The transient depletion of monocytes alone prior to exposure of macaques to HTLV-1 enhances both HTLV-1WT (wild type) and HTLV-1p12KO (Orf-1 knockout) infectivity, but seroconversion to either virus is not sustained over time, suggesting a progressive ...
Anna Gutowska   +12 more
doaj   +1 more source

Cancer vaccines: past, present and future; a review article

open access: yesDiscover Oncology, 2022
Immunotherapy and vaccines have revolutionized disease treatment and prevention. Vaccines against infectious diseases have been in use for several decades. In contrast, only few cancer vaccines have been approved for human use. These include preventative
Eddie Grimmett   +6 more
doaj   +1 more source

Immunogenicity and safety of xenogeneic vascular endothelial growth factor receptor-2 DNA vaccination in mice and dogs [PDF]

open access: yes, 2016
Vascular endothelial growth factor receptor-2 (VEGFR-2) is an attractive target in oncology due to its crucial role in angiogenesis. In this study a DNA vaccine coding for human VEGFR-2 was evaluated in healthy mice and dogs, administered by intradermal ...
Cicchelero, Laetitia   +3 more
core   +1 more source

p30 protein: a critical regulator of HTLV-1 viral latency and host immunity

open access: yesRetrovirology, 2019
The extraordinarily high prevalence of HTLV-1 subtype C (HTLV-1C) in some isolated indigenous communities in Oceania and the severity of the health conditions associated with the virus impress the great need for basic and translational research to ...
Ramona Moles   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy